• A Myriad of Issues: Supreme Court Rules on DNA Patents
  • June 19, 2013 | Authors: B. Logan Buck; W. Murray Spruill
  • Law Firm: Alston & Bird LLP - Durham Office
  • On Thursday, June 14, 2013, the United States Supreme Court unanimously ruled that the isolated form of naturally occurring DNA molecules does not rise to the level of patent-eligible subject matter. The ruling likely invalidates numerous issued patent claims directed to isolated DNA sequences. However, the Court also held that claims directed to complementary DNA (cDNA) molecules are patent-eligible because cDNA is not naturally occurring.